Event Dates
2017-06-12 - 2017-06-13
Organizer
Exhibitors
0
Event contact title
Contact
Event contact first name
John
Event contact last name
Collins
Email
jcollins@smi-online.co.uk
Event contact telephone number
44 207 827 6734
Description
SMi is delighted to announce the 12th annual ADMET conference returning to London in 2017!
ADMET technologies determine properties of a drug candidate in the preclinical stage of drug discovery, and poor ADMET properties are a major cause for a candidate to fail in drug development. ADME-Toxicology has allowed pharmaceutical manufacturing companies to minimize drug discovery time, complications and to reduce costs. The growing use of ADMET technologies is driving the market growth, which is estimated to reach $14,319.9 Million by 2022, with a CAGR of 10.6% from 2016 to 2022*. The main objective of early prediction of ADME properties is to increase the success rate of compounds reaching the development stage.
Attendee information
Benefits of attending:
oin us this year in June to hear from our expert speaker panel, bringing you interesting case studies and detailed presentations on new and industry relevant topics, including:
ADME/PK Optimisation for Drug Design and Discovery
Drug Screening Technology
In Vitro to Human In Vivo Translation
Physiologically Based PK Modeling
DMPK, PBPK, PKPD
Pre-/Clinical Toxicity
Accurate Human Dose Predictions
Transporters, Bioavailability, Formulation
Drug Delivery
Metabolism Studies
Drug-Drug Interactions
In vivo / in vitro / in silico
Hazard and Safety Assessment
Predictive Toxicology
Preclinical Pharmacology Testing